Handheld Devices for Injecting High Viscosity Drugs
|出版商||Greystone Research Associates||商品編碼||928151|
|注射高粘度藥用手持設備 Handheld Devices for Injecting High Viscosity Drugs|
|出版日期: 2020年03月11日||內容資訊: 英文||
Growth in high viscosity drugs is being driven by advances in biotechnology and host-vector engineering - advances that have led to a steady stream of biologics for a number of ailments and conditions. These powerful drugs come with a high cost-per-dose and the risk of significant side effects - factors that place an elevated emphasis on administration efficiency, safety and reliability. Many drugs in this class are characterized by physical properties and sensitivities that challenge the drug commercialization ecosystem. For example, monoclonal antibodies, perhaps the most significant category in terms of therapeutic and commercial importance, typically possess viscosities that are well above the normal limits of subcutaneous injection devices and techniques. Without a technical solution, these high viscosity drugs are formulated and supplied for infusion, a trend that threatens to put additional pressure on patient logistics and healthcare economics. Drug developers and device designers are increasingly working in collaboration to insure the commercial success of handheld devices for high viscosity injectables.
Comprehensive Analysis and Visualizations: